Aimei Health Technology Stock Market Value
AFJK Stock | 10.95 0.01 0.09% |
Symbol | Aimei |
Aimei Health Technology Company Valuation
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aimei Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aimei Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aimei Health.
12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Aimei Health on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Aimei Health Technology or generate 0.0% return on investment in Aimei Health over 90 days. Aimei Health is related to or competes with CD Projekt, Kaiser Aluminum, Meta Platforms, Galaxy Gaming, Motorsport Gaming, Jeld Wen, and Axcelis Technologies. Aimei Health is entity of United States. It is traded as Stock on NASDAQ exchange. More
Aimei Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aimei Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aimei Health Technology upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 0.7007 | |||
Information Ratio | 0.3338 | |||
Maximum Drawdown | 2.97 | |||
Value At Risk | (0.83) | |||
Potential Upside | 0.7605 |
Aimei Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aimei Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aimei Health's standard deviation. In reality, there are many statistical measures that can use Aimei Health historical prices to predict the future Aimei Health's volatility.Risk Adjusted Performance | 0.0883 | |||
Jensen Alpha | 0.0337 | |||
Total Risk Alpha | 0.0962 | |||
Sortino Ratio | 0.213 | |||
Treynor Ratio | (0.67) |
Aimei Health Technology Backtested Returns
As of now, Aimei Stock is very steady. Aimei Health Technology secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Aimei Health Technology, which you can use to evaluate the volatility of the firm. Please confirm Aimei Health's Mean Deviation of 0.2694, risk adjusted performance of 0.0883, and Downside Deviation of 0.7007 to double-check if the risk estimate we provide is consistent with the expected return of 0.0512%. Aimei Health has a performance score of 8 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0596, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aimei Health are expected to decrease at a much lower rate. During the bear market, Aimei Health is likely to outperform the market. Aimei Health Technology right now shows a risk of 0.46%. Please confirm Aimei Health Technology total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to decide if Aimei Health Technology will be following its price patterns.
Auto-correlation | 0.70 |
Good predictability
Aimei Health Technology has good predictability. Overlapping area represents the amount of predictability between Aimei Health time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aimei Health Technology price movement. The serial correlation of 0.7 indicates that around 70.0% of current Aimei Health price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.7 | |
Spearman Rank Test | 0.77 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Aimei Health Technology lagged returns against current returns
Autocorrelation, which is Aimei Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aimei Health's stock expected returns. We can calculate the autocorrelation of Aimei Health returns to help us make a trade decision. For example, suppose you find that Aimei Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Aimei Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aimei Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aimei Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aimei Health stock over time.
Current vs Lagged Prices |
Timeline |
Aimei Health Lagged Returns
When evaluating Aimei Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aimei Health stock have on its future price. Aimei Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aimei Health autocorrelation shows the relationship between Aimei Health stock current value and its past values and can show if there is a momentum factor associated with investing in Aimei Health Technology.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Aimei Health Correlation, Aimei Health Volatility and Aimei Health Alpha and Beta module to complement your research on Aimei Health. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Aimei Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.